WCLC 2022 Conference Coverage


 

WCLC 2022 on Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes With PD-L1 Blockade to Reverse Type-2 Mediated Immunosuppression

51 views
September 6, 2022
Comments 0
Login to view comments. Click here to Login